Qianhe Ren
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery.
Journal: Discover oncology
Published: August 19, 2025
Integrative multi-omic and machine learning approach for prognostic stratification and therapeutic targeting in lung squamous cell carcinoma.
Journal: BioFactors (Oxford, England)
Published: July 15, 2024
Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
Journal: Frontiers in immunology
Published: January 01, 2024
A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer.
Journal: Aging
Published: May 31, 2023
The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy.
Journal: Aging
Published: May 30, 2023
A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Journal: Frontiers in immunology
Published: April 02, 2023
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients.
Journal: BMC cancer
Published: February 05, 2023
The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinoma.
Journal: Frontiers in endocrinology
Published: January 30, 2023
Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
Journal: Frontiers in bioengineering and biotechnology
Published: January 11, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026